Document Detail


Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
MedLine Citation:
PMID:  23314386     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Fibrin-related markers may help differentiate disseminated intravascular coagulation (DIC) from liver cirrhosis-associated dysfunctional coagulation. We investigated the significance of three fibrin-related markers [D-dimer, fibrin degradation product (FDP), and soluble fibrin complexes (sFC)] for the assessment of DIC status and prognosis. We classified 235 patients with suspected DIC into two groups according to their condition: the liver cirrhosis group (n = 47) and the no liver cirrhosis group (n = 188). Prothrombin time (PT), and fibrinogen, sFC, D-dimer, antithrombin, and protein C concentrations were measured and DIC scores were calculated using four parameters: platelet count, D-dimer, fibrinogen, and PT. In the liver cirrhosis group, the sFC concentration increased significantly in accordance with DIC score compared with the no liver cirrhosis group, and this increase was more prominent than D-dimer and FDP concentration increases. For the diagnosis of overt DIC in patients with liver cirrhosis, the area under the concentration curve (AUC) was larger for sFC (0.746) than for D-dimer (0.733) and FDP (0.687). Cox analysis also indicated that an elevated sFC concentration is a more significant prognostic factor of DIC than D-dimer or FDP (hazard ratio: 10.78; P = 0.036) in liver cirrhosis group; however, it was not a prognostic factor in the no liver cirrhosis group. sFC is a powerful diagnostic and prognostic marker of DIC in patient with liver cirrhosis. The use of sFC is expected to enhance the diagnosis and prognosis of DIC, particularly in patients with liver cirrhosis.
Authors:
Seon Young Kim; Ji-Eun Kim; Hyun Kyung Kim; Inho Kim; Sung-Soo Yoon; Seonyang Park
Related Documents :
11816706 - Increased brain natriuretic peptide as a marker for right ventricular dysfunction in ac...
12811366 - A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2b7 in patients ...
15811146 - Predictors of glycaemic control in indigent patients presenting with diabetic ketoacido...
19398076 - Reduction in bnp levels with treatment of decompensated heart failure and future clinic...
15531456 - High prevalence of acquired von willebrand's syndrome in patients with thyroid diseases...
11924716 - Discriminating factors for recurrent hypertension in patients with primary aldosteronis...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-8
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  -     ISSN:  1473-5733     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
aDepartment of Laboratory Medicine bCancer Research Institute cDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of methylenetetrahydrofolate reductase A1298C polymorphism in cerebral venous thrombosis.
Next Document:  Comparison of three risk assessment methods for venous thromboembolism prophylaxis.